- Home
- WIX vs CORT Comparison
WIX vs CORT Comparison
Compare WIX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WIX | CORT |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.7B |
| IPO Year | 2013 | 2001 |
Fundamental Metrics
Financial Performance| Metric | WIX | CORT |
|---|---|---|
| Price | $88.09 | $32.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 23 | 6 |
| Target Price | ★ $150.04 | $105.20 |
| AVG Volume (30 Days) | ★ 2.4M | 1.7M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $761,407,000.00 |
| Revenue This Year | $15.55 | $29.97 |
| Revenue Next Year | $13.24 | $30.25 |
| P/E Ratio | ★ $28.86 | $39.50 |
| Revenue Growth | N/A | ★ 12.79 |
| 52 Week Low | $60.22 | $28.66 |
| 52 Week High | $190.92 | $117.33 |
Technical Indicators
Market Signals| Indicator | WIX | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 29.97 |
| Support Level | $75.00 | $28.66 |
| Resistance Level | $95.83 | $41.92 |
| Average True Range (ATR) | 4.65 | 1.63 |
| MACD | 2.23 | 0.13 |
| Stochastic Oscillator | 80.55 | 3.90 |
Price Performance
Historical ComparisonAbout WIX Wix.com Ltd.
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.